CARMEDA AB has a total of 55 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1988. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets medical technology, pharmaceuticals and macromolecular chemistry and polymers are ALLVIVO INC, WANG SHUFANG and GUAN QIANRU.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Australia | 7 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Canada | 6 | |
#6 | Japan | 4 | |
#7 | Brazil | 3 | |
#8 | United Kingdom | 3 | |
#9 | Norway | 3 | |
#10 | China | 2 | |
#11 | Hong Kong | 1 | |
#12 | Republic of Korea | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers | |
#4 | Surface technology and coating | |
#5 | Organic fine chemistry | |
#6 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Medical preparations | |
#5 | Devices for applying fluent materials | |
#6 | Peptides | |
#7 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Koch Eva | 14 |
#2 | Vestberg Robert | 13 |
#3 | Eriksson Malin | 11 |
#4 | Antoni Per | 11 |
#5 | Oscarson Stefan | 10 |
#6 | Porsch-Grahm Christian | 10 |
#7 | Leontein Karin | 10 |
#8 | Nyström Daniel | 8 |
#9 | Göransson Helena | 8 |
#10 | Gällhagen Anna | 8 |
Publication | Filing date | Title |
---|---|---|
WO2020070258A1 | Immobilised biological entities | |
US2019275213A1 | Immobilising biological entities | |
CA3093027A1 | Improvements to processes for immobilising biological entities | |
GB201110726D0 | Improvements to immobilised biological entities | |
GB201004101D0 | Immobilised biological entities | |
GB0816783D0 | Immobilised biological entities | |
US6767405B2 | Apparatus and process for coating articles | |
AU5765399A | Composition comprising heparin as a non-thrombogenic surface coating agent | |
AU5765299A | New process for preparing surface modification substances | |
EP0313538A2 | Monoclonal antibody, a process for its preparation and the use thereof |